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ABSTRACT  
High quality InAs/InP/ZnSe core/shell/shell quantum dots have been grown by a one-pot approach. This 
engineered quantum dots with unique near-infrared (NIR) fluorescence, possessing outstanding optical 
properties, and the biocompatibility desired for in vivo applications. The resulting quantum dots have 
significantly lower intrinsic toxicity compared to NIR emissive dots containing elements such as cadmium, 
mercury, or lead. Also, these newly developed ultrasmall non-Cd containing and NIR-emitting quantum dots 
showed signifi cantly improved circulation half-life and minimal reticuloendothelial system (RES) uptake. 
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Introduction
The use of quantum dots (QDs) for biomedical 
labeling is expected to be one of the first close-
to-real applications of nanomaterials [1, 2]. Near-
infrared (NIR) photoluminescence (PL) QDs, in 
particular, are likely to outperform other available 
biomedical labels for in vivo imaging because of 
their outstanding stability, large absorption cross 
section, and narrow emission bands [3 7]. However, 
NIR emitters for in vivo imaging must not only 
have optical performance requirements similar to 
their visible counterparts, but also should be small 
in hydrodynamic size, biocompatible, and free of 
extremely toxic class A elements, such as Cd, Pb, and 
Hg. Among all compound semiconductors, InAs-
based core/shell QDs are considered one of the most 
feasible systems for use as NIR biomedical labels 
[8]. Despite the challenging synthetic chemistry of 
such QDs, their potential advantages have inspired 
continuing signifi cant efforts [9 15] to develop high 
performance InAs-based NIR emitters. In general, 
the current challenges to overcome include low 
emission effi ciency, broad spectrum width, poor color 
control, poor stability, and/or cadmium content. This 
work was designed to provide solutions to these 
problems that also offer acceptable biocompatibility 
for the QDs, including the necessary physiological 
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permeability, biochemical stability, negligible non-
specific bonding, long circulation half-life, low 
cytotoxicity, and minimal reticuloendothelial system 
(RES) uptake.
Biological tissues are transparent in the NIR 
optical window (roughly between 700 and 1100 nm). 
Thus, if fluorescent labels can be both excited and 
detected efficiently in this optical window, related 
imaging techniques will enable imaging of live tissue 
without tedious isolation processes, and possibly 
even allow imaging directly in a biological body 
[16]. To fully exploit the in vivo advantages of NIR 
probes, the hydrodynamic size of the QDs should 
be less than about 10 nm and they should be stable 
under physiological conditions with little or no non-
specific binding. Considering the thickness of the 
ligands, the inorganic nanocrystal core itself should 
be around 6 7 nm in size. Because of the well-known 
instability of plain core semiconductor nanocrystals, 
a shell with a few monolayers of wide band-gap 
semiconductor (commonly ZnSe or ZnS) is necessary, 
a requirement that further reduces the maximum size 
of the emissive part of the inorganic nanocrystals to 
below 3 nm. Among commonly known Ⅱ Ⅵ and Ⅲ
Ⅴ semiconductors, only a select few can satisfy these 
requirements, such as mercury/lead chalcogenides 
and InAs [8]. Mercury and lead, however, are too 
intrinsically toxic to be considered. Although indium, 
arsenic, zinc, phosphorus, and selenium are also 
toxic, the human body can tolerate a certain level of 
exposure to all of these elements [8].  
1. Experimental
Synthesis of InAs QDs and InAs/InP/ZnS QDs. The 
InAs QDs were synthesized following a procedure 
to be published elsewhere. The resulting InAs cores 
were cooled to 110 ºC. Without purification, 0.3 
mmol stearic acid (in 0.5 mL octadecene (ODE)) was 
injected into the reaction solution, and then a mixture 
of 1 mmol octylamine (0.2 mL) and 0.2 mmol tris-
(trimethylsilyl)phosphine ((TMS)3P) in ODE (0.8 
mL) was then added dropwise into the reaction 
solution. After addition of the P precursor, the 
mixture was heated to 178 ºC and the temperature 
maintained for 45 min in order to allow growth of 
the InP shell onto the InAs core. When the indium 
precursor had been consumed, 0.04 mmol Se in tri-n-
octylphosphine (TOP) (0.2 mL) was injected followed 
by the zinc precursor zinc undecylenate. The reaction 
temperature was then increased to 220 ºC for 30 min 
to allow growth of the ZnSe shell. 
Characterization of the QDs. Characterization 
of the QDs was carried out using a Titan microscope 
with an acceleration voltage of 300 kV for transmission 
electron microscopy (TEM) measurements, an HP 8453 
diode array spectrophotometer for absorption spectra, 
and a Spex Fluorolog 3 111 for PL measurements.
Serum stability of QDs. InAs/InP/ZnSe QDs 
dispersed in 100% fetal calf serum was kept at 37 ºC. 
The PL intensity of the QDs in serum was measured 
at different times. 
MTT assay of QDs. RAW 264.7 cells (mouse 
macrophage cell line) were seeded in a 96-well plate 
at a density of 5000 cells/well on the day before the 
addition of the QDs. InAs/InP/ZnSe QDs or QD 800 
ITK carboxyl ("QD800") CdTe/ZnS core/shell dots 
(Invitrogen) were incubated with cells in RPMI 1640 
cell culture medium in a cell culture incubator. The 
survival rates of the macrophage cells at 24 h and 
48 h time points after dot incubation were measured 
by MTT assay. After 3 h incubation at 37 ºC, the 
MTT working solution was removed. Then 200 μL 
DMSO was added into each well and the plate was 
shaken for 20 min at room temperature. All samples 
were assayed in triplicate and the survival rate was 
calculated as follows: survival rate = (Atreat/Acontrol) × 
100%.
In vivo and ex vivo imaging. Athymic nude 
mice were each injected by tail vein with 0.5 nmol of 
QDs. The mice were imaged at multiple time points 
postinjection (p.i.) using the Maestro in vivo imaging 
system (CRI Inc., Woburn, MA). After spectral 
unmixing, coronal images of multi-time points were 
obtained for comparison. The animals were then 
sacrifi ced at 24 h p.i. After major organs were harvested, 
NIR imaging was done using the IVIS 200 imaging 
system (Caliper Life Sciences, Hopkinton, MA).
Circulation half-life measurement. In order to 
measure the half-life of the InAs/InP/ZnSe QDs and 
Qdot 800 ITK carboxyl ("QD800") CdTe/ZnS core/
shell dots (Invitrogen), nude mice were tail vein-
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Figure 1 (a) UV Vis NIR spectra of InAs samples with different sizes. The evolution of the absorption 
and PL spectra upon consecutive growth of the concentric shells is shown in (b), (c) and (d). The spectra 
labeled with the letters (b) (d) were taken from samples with TEM images as shown in (e), (f) and (g), 
respectively. The insets show the corresponding HR-TEM micrographs 
injected with 0.5 nmol of QDs and a blood sample 
(approximately 3 5 μL) was taken from the tail 
vein of the mice at different time points p.i. and PL 
intensity of the blood samples was measured by the 
IVIS 200 imaging system. 
2. Results and discussion
The synthesis of high quality InAs core nanocrystals 
with the desired sizes (<3 nm) for in vivo applications 
has been a challenge in the fi eld [9, 10, 13, 15]. In any 
case, the emission properties of InAs QDs reported 
so far are poor, with a weak and broad band-gap 
emission peak for the plain core dots. We recently 
developed a new synthetic strategy by applying the 
“self-focusing” method [17], which yielded InAs 
nanocrystals with their fi rst exciton absorption peak 
ranging roughly from 550 nm to 1050 nm without 
any size sorting (Fig. 1(a)), matching the needs for 
NIR emitters. The outstanding properties of the InAs 
core nanocrystals generated by this new synthetic 
strategy formed the basis of this study. 
The InAs core nanocrystals prepared by the 
new scheme showed a weak but narrow band edge 
PL peak without size sorting (Fig. 1(b)). After the 
epitaxial growth of 1 3 monolayers of an InP shell 
onto the InAs nanocrystals 
u s i n g  t h e  s u c c e s s i v e 
ionic layer adsorption 
and  reac t ion  (S ILAR) 
technique [18] (Fig. 1(f)), 
the PL QY did not increase 
s i g n i f i c a n t l y,  b u t  t h e 
emission peak position 
could be s ignif icantly 
t u n e d  b y  t h i s  i n n e r 
shell (Fig. 1(c)). Direct 
epitaixal growth of ZnSe 
or ZnS shells onto the InAs 
nanocrystals improved the 
PL QY signifi cantly, usually 
in the range of 20% 35% for 
ZnSe shells. Moreover, with a 
few monolayers of an InP 
buffer shell, subsequent 
epitaxial growth of the 
ZnSe shell (Fig. 1(g)) through a one-pot approach 
greatly improved the emissive brightness of the 
nanocrystals, with PL QY in the range 40% 90% (Fig. 
1(d)). It should be noted that the InAs/InP/ZnSe 
core/shell/shell QDs have been previously reported 
by the Bawendi group [8]. Although the PL QY of 
the nanocrystals in their report was as low as 3%
5%, some interesting biomedical properties observed 
there provided signifi cant inspiration for the current 
work. 
Using our procedure, the InAs plain core and 
InAs/InP core/shell nanocrystals were not only dim 
in emission but also unstable even under ambient 
conditions (Fig. 2(a)). The additional epitaxial growth 
of the ZnSe shell, however, greatly improved the 
stability of the resulting nanocrystals (Fig. 2(b)). 
Preliminary results indicate that the InAs/InP/
ZnSe/ZnSe core/shell/shell nanocrystals dissolved 
in nonpolar solvents did not show any signs of 
emission decay under ambient conditions for at least 
4 months.   It is also noteworthy that the InAs-based 
core/shell/shell QDs showed increased PL QY and 
improved stability only with about 2 3 monolayers 
of epitaxially grown ZnSe shell (Fig. 2(d)). 
The PL peak width, measured by the full-
width-at-half-maximum (FWHM), dictates the 
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number of possible biomedical 
labels within the transparent NIR 
window. The FWHM for the InAs 
core nanocrystals  made by the 
new strategy was substantially 
narrower than those reported in 
the literature [8 10]. For example, 
with a UV vis peak at around 800 
nm, the PL FWHM of the InAs 
core nanocrystals obtained by the 
new strategy was about 55 65 nm 
(Fig. 1(b)), instead of around 100 120 
nm as observed previously for the 
nanocrystals with a similar size and 
size distribution. Importantly, after 
growth of the InP and ZnSe shells, 
the PL FWHM (60 75 nm) did not 
change substantially (Fig. 2(c)). It 
should be pointed out that, given a 
similar size and size distribution, a 
narrow band gap PL peak usually 
indicates that the surface of the 
corresponding nanocrystals is more 
homogeneous [11, 12], which should 
endow the one-pot growth of the 
final core/shell/shell dots with 
outstanding qualities substantially 
improved PL QY and narrower 
PL peak in comparison to those 
reported previously that have similar 
structures [8]. 
The InAs-based QDs coated with 
nonpolar ligands can be readily 
transferred into aqueous solution 
by treatment with hydrophilic thiol 
ligands, such as mercaptopropionic 
acid (MPA), under basic conditions 
(Fig. 3(a)). Typically, the PL QY and 
PL peak width can be maintained 
on being transferred into water 
(Fig. 3(b)). More importantly, the 
resulting water-soluble nanocrystals 
were stable in water under ambient 
conditions. The hydrodynamic sizes 
of the InAs-based QDs in water 
were controlled to be below 10 nm. 
Figure 3 (a) Schematic representation of ligand exchange process to prepare core / shell /
shell dots using MPA; (b) the QY of as-obtained three core / shell / shell dots dispersed 
first in toluene and then in water; (c) dynamic light scattering measurements of the 
hydrodynamic diameter of exchanged core / shell / shell dots with MPA in water. Inset is 
the TEM image of core / shell / shell quantum dots in water
Figure 2 Air stability of (a) InAs and (b) InAs/InP/ZnSe core/shell dots. The evolution of PL 
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Figure 4 UV vis NIR and PL spectra of core / shell / shell dots in (a) serum and (b) water; (c) digital pictures of core / shell / shell 
dots in water and serum, and pure serum under UV light; (d) PL intensity of the core / shell / shell dots recorded over 2 days 
of incubation in serum at 37 ºC; (e) digital pictures of core / shell / shell nanocrystal sample in serum before and after 
centrifugation; (f) UV vis NIR and PL spectra of the supernatant of the sample in (e) 
The example in Fig. 3(c), with its PL peak position at 
940 nm, was determined to have average diameter 
of about 8 9 nm by dynamic light scattering. This 
hydrodynamic size approximately matched the 
size estimated from the physical dimensions of the 
nanocrystals i.e., a ~6 nm inorganic nanocrystal with 
a ~1.4 nm ligand shell. By TEM, these water-soluble 
QDs were found be well separated as individual dots 
(Fig. 3(c), inset). 
The results above demonstrate that the InAs-
based QDs presented here are extremely bright, 
chemically stable, tunable in emission color in the 
targeted NIR window, and below the requisite 
10 nm size threshold for in vivo applications in 
water. To examine the biostability of the water-
soluble InAs/InP/ZnSe core/shell/shell dots, 
they were mixed with pure serum obtained from 
commercial sources. Figure 4 shows that the 
emission properties of the dots did not change 
after mixing with the serum. After removing the 
significant scattering background caused by the 
large particles in serum (dashed line in Fig. 4(a)), 
the absorption spectrum (not shown) of the InAs/
InP/ZnSe core/shell/shell dots in serum was 
essentially the same as that of the dots in water (Fig. 
4(b)). Figure 4(c) indicates that, despite the strong 
scattering and absorption by the serum medium 
(barely transparent), the deep red emission of the 
core/shell sample was nearly the same as that of 
the dots in pure water. This is consistent with the 
transparent features of the biological system in the 
deep red and the NIR window mentioned above. 
Upon incubation in the serum under typical body 
temperature (37 ºC) for at least 2 days, the emission 
properties of the InAs/InP/ZnSe core/shell/shell 
dots were found to remain unchanged. These 
results clearly indicate no noticeable aggregation 
of the dots under the physiological conditions 
employed. 
We conducted some preliminary studies on the 
non-specifi c bonding of InAs/InP/ZnSe core/shell/
shell dots onto biological species in serum. This was 
performed by high-speed centrifugation (14 000 
rpm) of the incubated mixture of the dots and serum 
(incubated for 1 day at 37 ºC). The picture in Fig. 4(e) 
(left) illustrates the strong scattering of the mixture 
caused by the biomolecule suspensions in serum 
before centrifugation. As a result, the letters “InAs 
NCs” behind the cuvette were barely visible. Upon 
centrifugation, the supernatant became optically 
clear, which made it possible to see the letters “InAs 
NCs” behind the optical cuvette (Fig. 4(e), right). 
462 Nano Res (2008) 1: 457 464
Nano Research
Figure 5 In vitro and in vivo characterization of quantum dots: (a) In vitro toxicity of quantum dots measured by MTT 
assay using mouse macrophage cell line RAW 264.7; (b) in vivo NIR fl uorescence imaging of athymic nude mice injected 
with 0.5 nmol of InAs / InP /ZnSe core / shell / shell dots (bottom) and Invitrogen Qdot 800 ITK carboxyl ("QD800") CdTe /ZnS 
core / shell dots (top); (c) ex vivo fl uorescence imaging of major organs of mice at 24 h post injection: 1, liver; 2, spleen; 3, 
heart; 4, muscle; 5, left kidney; 6, right kidney; 7, lung; 8, bone
This means that most of the scattering biomolecules 
were successfully removed by the centrifugation 
process. The optical properties of the InAs/InP/
ZnSe core/shell/shell dots in the supernatant (Fig. 
4(f)), however, showed identical absorbance and PL 
emission intensity. This indicates that the non-specifi c 
bonding of the InAs/InP/ZnSe core/shell/shell dots 
to large-sized biomolecules present in the serum 
was negligible, if present at all. This interesting 
phenomenon and the non-aggregation features 
of the dots in the serum are positive proof of the 
potential for in vivo biomedical applications of the 
dots. Although the exact mechanism(s) underlying 
the encouraging results in Fig. 4 needs further 
clarification, some preliminary biomedical tests to 
be discussed below further confirmed the excellent 
performance of the InAs/InP/ZnSe core/shell/shell 
dots for biomedical labeling (Fig. 5). 
To  fur ther  explore  the  potent ia l  in  v ivo 
applications of InAs/InP/ZnSe core/shell/shell 
dots, we studied their cytotoxicity in vitro, circulation 
half-life, and major organ distribution in vivo. The 
results were compared with a standard commercial 
product with its PL in the similar NIR window, QD 
800 ITK carboxyl ("QD800") CdTe/ZnS core/shell 
dots (Invitrogen). MTT assay (Fig. 5(a)) revealed 
significantly less cytotoxicity of InAs/InP/ZnSe 
core/shell/shell dots as compared to CdTe/ZnS 
core/shell dots. When incubated with RAW 264.7 
mouse macrophage cells, QD800 had significantly 
higher cell uptake and retention than InAs/InP/
ZnSe core/shell/shell dots (data not shown). Non-
invasive fluorescence imaging (Fig. 5(b)) revealed 
signifi cantly higher and more prolonged liver uptake 
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for the CdTe/ZnS core/shell dots. In the meantime, 
mice urine was collected at 1 h post injection 
and fluorescence intensity was measured.  After 
normalization by quantum yield and injection dose, 
the percentage of urine clearance of InAs/InP/ZnSe 
core/shell/shell dots was 0.033%/μL. The amount of 
InAs/InP/ZnSe core/shell/shell dots was 2.79 times 
the amount of CdTe/ZnS core/shell dots, which 
strongly indicated renal clearance of InAs/InP/ZnSe 
core/shell/shell dots. Ex vivo imaging of major 
organs and tissues at 24 h after intravenous injection 
of QDs (Fig. 5(c)) confi rmed much lower liver signals 
from mice injected with InAs/InP/ZnSe core/shell/
shell dots than those injected with CdTe/ZnS core/
shell dots. The higher signals from the kidneys of 
mice injected with InAs/InP/ZnSe core/shell/shell 
dots suggest renal clearance of this type of non-
cadmium-based QDs. 
The decrease in fluorescence signals of both 
particles in the blood circulation was followed by 
one-phase exponential decay with the circulation 
half-life for InAs/InP/ZnSe core/shell/shell dots 
being as long as 110 min, whereas the half-life for 
CdTe/ZnS core/shell dots was only 6 min. The 
short circulation half-life of CdTe/ZnS core/shell 
dots measured from fluorescence spectrometry is 
consistent with our previous results reported in the 
literature [19, 20]. 
3. Conclusions
InAs/InP/ZnSe core/shell/shell dots grown by the 
one-pot approach can be engineered as unique NIR 
fluorescence labels that possess outstanding optical 
properties and the biocompatibility desired for in 
vivo applications. Although the dots still contain 
different types of toxic elements such as In, As, P, 
Zn, and Se, the intrinsic toxicity of the resulting dots 
is significantly reduced compared to NIR emissive 
dots containing cadmium, mercury, or lead. These 
potential labels have higher brightness, higher molar 
extinction coefficient, broader absorption bands 
covering an optical window from NIR to UV, and 
sharper PL peaks in the NIR window than NIR-
emitting organic dyes and/or existing QDs. The 
hydrodynamic sizes of the resulting bright NIR 
core/shell/shell dots in water can be controlled 
to be below the required 10 nm threshold. These 
water-soluble InAs/InP/ZnSe core/shell/shell dots 
were found not to aggregate under physiological 
conditions tested, and their non-specific bonding to 
large sized biomolecules was insignificant. Finally, 
these newly developed ultrasmall non-Cd and 
NIR-emitting QDs showed significantly improved 
circulation half-life and minimal RES uptake. With 
such unique and desirable properties, these high-
performance NIR emission dots should offer a new, 
attractive platform for exploring biomedical labeling 
using colloidal QDs, especially for in vivo molecular 
imaging applications.  
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